Waldron Private Wealth LLC decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the 3rd ...

Eastern Bank increased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 145.8% in the 3rd quarter, according ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their ...

As an investor in Eli Lilly stock, I'm encouraged by the company's forward thinking. Not only is management making moves to ...

Bernstein has recently initiated Eli Lilly And Co (LLY) stock to Outperform rating, as announced on October 17, 2024, according to Finviz. Earlier, on September 13, 2024, Citigroup had resumed the ...

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...

The justices are considering an effort challenging longstanding case law blocking the state’s ability to probe inflated drug ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other Most Promising Growth Stock According to Hedge Funds. Investors had been anxiously ...

Eli Lilly (LLY) is suing medical spas and online vendors who claim their products contain the main ingredients of GLP-1 weight-loss drug Zepbound, according to Reuters. Lastly, Bloomberg reports that ...